v3.26.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2026
Debt Instrument [Line Items]  
Schedule of the Tranche B Note

The following table provides a summary of the changes in the balance and the estimated fair value of the Tranche B Notes (in thousands):

 

 

March 31,

 

 

2026

 

Ending Balance as of December 31, 2025

$

17,500

 

Repayment of Tranche B Notes principal and interest

 

(6,319

)

Change in fair value of Tranche B Notes

 

829

 

Ending Balance as of March 31, 2026

$

12,010

 
Schedule of revenue liability activity

The following table summarizes the purchased revenue liability activity related to ZTlido Royalty Purchase Agreement during the three months ended March 31, 2026 (in thousands):

 

 

March 31,

 

 

2026

 

Ending Balance as of December 31, 2025

$

6,100

 

Repayment of purchased revenue liability

 

(750

)

Change in fair value of purchased revenue liability

 

650

 

Ending Balance as of March 31, 2026

$

6,000

 

 

March 31,

 

 

2026

 

Ending Balance as of December 31, 2025

$

2,300

 

Repayment of purchased revenue liability

$

(44

)

Change in fair value of purchased revenue liability

 

144

 

Ending Balance as of March 31, 2026

$

2,400

 
Oramed Note [Member]  
Debt Instrument [Line Items]  
Schedule of the Oramed Note

The following table provides a summary of the changes in the balance and the estimated fair value of the Oramed Note (in thousands):

 

 

March 31,

 

 

2026

 

Ending Balance as of December 31, 2025

$

27,688

 

Change in fair value of Oramed Note – recorded in the unaudited condensed consolidated statements of operations

 

1,174

 

Ending Balance as of March 31, 2026

$

28,862